Rani Therapeutics (United States)

Recent papers from Rani Therapeutics (United States)

1. Evaluation of the safety, efficacy and dosimetry of TRC003 in metastatic castration-resistant prostate cancer: A prospective, open-label, single-arm study.Journal of Clinical Oncology · 2026
2. Oral delivery of an ustekinumab biosimilar with bioavailability comparable to subcutaneous administration in healthy human participantsEuropean Journal of Clinical Pharmacology · 2026
3. An oral robotic pill reliably and safely delivers teriparatide with high bioavailability in healthy volunteers: A phase 1 studyBritish Journal of Clinical Pharmacology · 2025
4. Preference for a Novel Oral Alternative to Parenterally Administered MedicationsPatient Preference and Adherence · 2024
5. Ecological Robustness-Oriented Grid Network Design for Resilience Against Multiple HazardsIEEE Transactions on Power Systems · 2023
6. Transenteric delivery of antibodies via an orally ingestible robotic pill yields high bioavailability comparable to parenteral administration in awake caninesFrontiers in Drug Delivery · 2022
7. A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjectsDrug Delivery and Translational Research · 2021
8. Jejunal wall delivery of insulin via an ingestible capsule in anesthetized swine—A pharmacokinetic and pharmacodynamic studyPharmacology Research & Perspectives · 2019